During the past decade, Loema Instituto de Pesquisa Clinica conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Loema Instituto de Pesquisa Clinica" are "Obesity" (4 trials), "Overweight" (3 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Loema Instituto de Pesquisa Clinica" in a lesser frequency.

Most popular intervention types in "Loema Instituto de Pesquisa Clinica" are "Drug" (7 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Tirzepatide" (5 trials), "Romiplostim" (2 trials), "Dulaglutide" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

The vast majority of trials in "Loema Instituto de Pesquisa Clinica" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Loema Instituto de Pesquisa Clinica". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Loema Instituto de Pesquisa Clinica, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Loema Instituto de Pesquisa Clinica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".